Corporate News     17-Apr-18
AstraZeneca announces investment of USD 90 mn in India
To develop local skills, build scientific innovation and promote quality manufacturing
AstraZeneca announced its decision of further investing $ 90 million over the next 5 years in India. The announcement was made following a meeting between the company's Executive Vice President for International Region – Leon Wang and Prime Minister of India, Narendra Modi, during the latter's visit to Sweden, where the two countries signed a joint declaration on innovation partnership for a sustainable future.

This investment commitment will span across AstraZeneca's diverse footprint in India with an aim to strengthen its manufacturing, clinical operations, patient safety & regulatory science, IT services and commercial operations. Furthermore this investment will support scientific data generation, quality manufacturing, science talent development and collaborative development of innovative solutions to improve the standard of care of non-communicable diseases in India.

Previous News
  Astrazeneca Pharma India standalone net profit declines 38.28% in the March 2023 quarter
 ( Results - Announcements 31-May-23   07:43 )
  Nifty above 22,950; European mkt opens lower
 ( Market Commentary - Mid-Session 28-May-24   13:43 )
  Astrazeneca Pharma India standalone net profit rises 172.47% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   17:08 )
  AstraZeneca Pharma Q4 PAT soars 129% YoY to Rs 39 cr
 ( Hot Pursuit - 28-May-24   11:45 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 10-Aug-20   16:20 )
  AstraZeneca Pharma India fixes record date for dividend
 ( Market Beat - Reports 03-Jul-23   18:19 )
  AstraZeneca receives DCGI approval for launch of Olaparib Film-Coated tablets in India
 ( Corporate News - 19-Aug-22   19:06 )
  Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter
 ( Results - Announcements 07-Aug-19   16:27 )
  Volumes jump at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 12-Sep-22   14:30 )
  Astrazeneca Pharma India standalone net profit declines 13.43% in the June 2020 quarter
 ( Results - Announcements 10-Aug-20   14:40 )
  Astrazeneca Pharma India to table results
 ( Corporate News - 02-Aug-22   10:54 )
Other Stories
  Vardhan Capital & Finance schedules AGM
  06-Jul-24   17:34
  Automotive Axles schedules AGM
  06-Jul-24   17:34
  Maruti Infrastructure to conduct AGM
  06-Jul-24   17:34
  Torrent Power schedules AGM
  06-Jul-24   17:34
  Raghav Productivity Enhancers to hold AGM
  06-Jul-24   17:34
  Berger Paints India schedules AGM
  06-Jul-24   17:33
  Walpar Nutritions to conduct AGM
  06-Jul-24   17:33
  Weizmann AGM scheduled
  06-Jul-24   17:33
  Gretex Industries schedules AGM
  06-Jul-24   17:33
  Karma Energy schedules AGM
  06-Jul-24   17:33
Back Top